Cover Image

Guidance for industry and FDA : current good manufacturing practice for combination products.

Bibliographic Details
Corporate Author:	United States. Food and Drug Administration. Office of Combination Products
Format:	Government Document eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Office of the Commissioner, Office of Combination Products, [2004]
Subjects:	Drug development > Government policy > United States. Chemotherapy, Combination > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS112968

Similar Items

Guidance for industry and FDA staff : how to write a request for designation (RFD).
Published: (2005)

Guidance for industry and FDA staff : application user fees for combination products.
Published: (2005)

Guidance for industry and FDA staff : submission and resolution of formal disputes regarding the timeliness of premarket review of a combination product.
Published: (2004)

Persantine-aspirin reinfarction study : design, methods, and baseline results /
Published: (1980)

Guidance for industry and FDA staff : early development considerations for innovative combination products.
Published: (2006)

Combination therapy against multidrug resistance /
Published: (2020)

Guidance for industry : influenza, developing drugs for treatment and/or prophylaxis.
Published: (2009)

Combined antimicrobial therapy : proceedings of the International Workshop on Combined Antimicrobial Therapy, held in Rome, April 21-22, 1978, in collaboration with Universita di Roma, Facolta di scienze, 2. cattedra di microbiologia /
Published: (1979)

Guidance for industry : community-acquired bacterial pneumonia : developing drugs for treatment.
Published: (2009)

Combination drug delivery approach as an effective therapy for various diseases /
Published: (2022)

Adjuvant chemotherapy for breast cancer : January 1980 through August 1985, 403 citations in English /
by: Kenton, Charlotte
Published: (1985)

Guidance for FDA staff and industry : marketed unapproved drugs, compliance policy guide.
Published: (2006)

Integrating pharmacotherapy and psychotherapy /
Published: (1991)

Guidance : PET drug products, current good manufacturing practice (CGMP).
Published: (2005)

Combinatietherapie bij reumatoide artritis : prioriteiten voor toekomstig onderzoek /
Published: (2001)

Guidance for industry : manufacturing, processing, or holding active pharmaceutical ingredients.
Published: (1998)

Guidance for industry : Q3B(R2) impurities in new drug products.
Published: (2006)

Combined treatments for mental disorders : a guide to psychological and pharmacological interventions /
Published: (2001)

Guidance for industry : E 11 clinical investigation of medicinal products in the pediatric population.
Published: (2000)

Guidance for industry, FDA staff, and FDA-accredited third parties.
Published: (2009)

Guidance for industry : PAT, a framework for innovative pharmaceutical development, manufacturing, and quality assurance.
Published: (2004)

Guidance for industry : Q3A impurities in new drug substances.
Published: (2008)

Guidance for industry : street drug alternatives.
Published: (2000)

Draft guidance for industry and FDA staff : technical considerations for pen, jet, and related injectors intended for use with drugs and biological products.
Published: (2009)

Regression analysis of survival data in cancer chemotherapy /
by: Carter, Walter H., 1941-
Published: (1983)

Alternative mechanisms of multidrug resistance in cancer /
Published: (1995)

Guidance for industry : Q8(R2) pharmaceutical development.
Published: (2009)

Guidance for industry : fast track drug development programs, designation, development and application review.
Published: (2004)

Guidance for industry : fast track drug development programs, designation, development and application review.
Published: (2006)

Combined pharmacotherapy and psychotherapy for depression /
Published: (1990)

Health innovations.
Published: (2018)

Guidance for industry : population pharmacokinetics.
Published: (1999)

Guidance for industry : formal meetings between the FDA and sponsors or applicants.
Published: (2009)

FDA checkup : drug development and manufacturing challenges : hearing before the Subcommittee on Energy Policy, Health Care and Entitlements of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Thirteenth Congress, first session, December 12, 2013.
Published: (2014)

Guidance for industry : premarketing risk assessment.
Published: (2005)

Combined sewer overflows : guidance for financial capability assessment and schedule development.
Published: (1997)

Combined sewer overflows : guidance for funding options.
Published: (1995)

Regional cancer therapy /
Published: (2007)

Report to Congress : implementation and enforcement of the combined sewer overflow control policy.
Published: (2001)

National combined sewer overflow control strategy.
Published: (1989)